FDA warns Curaleaf about inflated claims in CBD product marketing

0 40



A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is …

source

Leave A Reply

Your email address will not be published.